Skip to main content

Table 3 Diagnostic performance of the significant predictors in the training and validation cohorts

From: An MRI-based radiomics nomogram for detecting cervical esophagus invasion in hypopharyngeal squamous cell carcinoma

 

AUC

Accuracy

Sensitivity

Specitivity

Training cohort

    

 Primary site

0.652 (0.550, 0.754)

64.4 (63.9, 64.8)

69.2 (54.7, 83.7)

61.3 (49.2, 73.4)

 Clinical T stage

0.647 (0.573, 0.721)

58.4 (57.9, 58.9)

92.3 (83.9, 100)

37.1 (25.1, 49.1)

 Radiomics signature

0.916 (0.866, 0.967)

80.2 (79.9,80.5)

97.4 (92.5, 100)

69.4 (57.9, 80.8)

Validation cohort

    

 Primary sites

0.598 (0.446, 0.749)

62.0 (61.1, 62.9)

69.2 (51.5, 87.0)

54.2 (34.2, 74.1)

 Clinical T stage

0.692 (0.572, 0.812)

70.0 (69.2,70.8)

88.5 (76.2, 100)

50.0 (30.0, 70.0)

 Radiomics signature

0.865 (0.762, 0.969)

82.0 (81.4, 82.6)

84.6 (70.7, 98.5)

79.2 (62.9, 95.4)

  1. Data are presented as percentages, except AUC; 95% confidence intervals are included in parentheses
  2. AUC, area under the curve